Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Lowdose Wholefoodbased Magnesium Supplement

Research Leaders

5 sponsors active, led by Zhilei Shan

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total

Not Applicable (3)

Trial Status

Not Yet Recruiting2

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials

NCT07865351Not ApplicableNot Yet RecruitingPrimary

Whole-Food Magnesium for Mental and Cardiometabolic Health

NCT07713316Not ApplicableCompletedPrimary

Understanding the Paradoxical Rise in Blood Glucose in the Context of a Low-carbohydrate Diet

NCT06807996Not ApplicableNot Yet RecruitingPrimary

Effects of Zinc Supplementation on Patients With Elevated Glycemic Status

Showing all 3 trials

Research Network

Common Treatments

Lowdose Wholefoodbased Magnesium Supplement1
Moderatedose Wholefoodbased Magnesium Supplement1
Edible Yeast Placebo Capsule1
Protein Drink1
Fat Drink1

Active Sponsors

Zhilei Shan1
Standard Process Inc.1
Levels Health Inc.1
Brigham Young University1
George Mason University1

Elevated Blood Glucose